File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial

TitleNovel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial
Authors
Issue Date2017
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD): The Liver Meeting 2017, Washington, DC, USA, 20-24 October 2017. In Hepatology, 2017, v. 66 n. 6, Suppl., p. 1269A-1270A, abstract no. LB-25 How to Cite?
DescriptionLate‐Breaking Abstract
Persistent Identifierhttp://hdl.handle.net/10722/264593
ISSN
2017 Impact Factor: 14.079
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorLocarnini, S-
dc.contributor.authorWong, DKH-
dc.contributor.authorJackson, K-
dc.contributor.authorWalsh, R-
dc.contributor.authorEdwards, R-
dc.contributor.authorHammond, R-
dc.contributor.authorMacfarlane, C-
dc.contributor.authorIyer, RP-
dc.contributor.authorAfdhal, NH-
dc.contributor.authorYuen, RMF-
dc.date.accessioned2018-10-22T07:57:31Z-
dc.date.available2018-10-22T07:57:31Z-
dc.date.issued2017-
dc.identifier.citationThe 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD): The Liver Meeting 2017, Washington, DC, USA, 20-24 October 2017. In Hepatology, 2017, v. 66 n. 6, Suppl., p. 1269A-1270A, abstract no. LB-25-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/264593-
dc.descriptionLate‐Breaking Abstract-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofThe 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD): The Liver Meeting 2017-
dc.titleNovel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial-
dc.typeConference_Paper-
dc.identifier.emailWong, DKH: danywong@hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityWong, DKH=rp00492-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros293854-
dc.identifier.volume66-
dc.identifier.issue6, Suppl.-
dc.identifier.spage1269A-
dc.identifier.epage1270A-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats